GHK-Cu is a tripeptide — glycine-histidine-lysine — complexed with a copper(II) ion. It was first isolated from human plasma by Pickart and Thaler in 1973, where it was observed to stimulate liver cell growth in culture. The key structural feature is the histidine residue at position 2, which forms a tetragonal coordination complex with Cu²+ alongside the N-terminal amine and the peptide nitrogen. This copper-binding geometry is the molecular fingerprint that makes GHK-Cu biologically distinctive from uncomplexed GHK.
Plasma concentrations of GHK follow a well-documented age-related decline: approximately 200 ng/mL in healthy young adults, falling to roughly 80 ng/mL by age 60. Researchers have proposed this decline as a partial contributor to the gradual reduction in tissue repair efficiency observed with ageing — a hypothesis supported by the transcriptomic evidence reviewed below.
In research contexts, GHK-Cu has been investigated across several overlapping domains:
REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched GHK-Cu across all 7 emirates for investigators operating in research contexts. The peptide is available as lyophilized powder in 50mg and 100mg vials — see the GHK-Cu UAE product page for current stock and pricing.
The landmark contribution of Campbell et al. (2012, BMC Genomics) was a systematic transcriptomic analysis examining the effect of GHK on human gene expression. Using microarray data from the Broad Institute Connectivity Map (cMap) dataset, the investigators identified genes whose expression patterns were most strongly influenced by GHK exposure. The study context was emphysema-associated lung tissue destruction — and what the data revealed was that GHK could modulate a substantial portion of the gene-expression changes underlying that pathological process, including a well-defined cluster of DNA-repair genes.
The Campbell analysis revealed that GHK modulated 31 genes with direct or indirect roles in the DNA-damage response (DDR) network. These spanned four major repair arms:
Critically, the direction of modulation was largely restorative. GHK appeared to upregulate repair pathways that are typically downregulated in aged, inflamed, or oxidatively stressed tissue. The Campbell team proposed that this gene-modulation signature could help explain GHK's documented regenerative effects, which had previously been attributed almost exclusively to collagen and MMP dynamics.
| DNA-Repair Pathway | Direction Under GHK | Biological Significance |
|---|---|---|
| Base-excision repair (BER) | Upregulated | Removes oxidised DNA bases (8-oxoguanine, AP sites) |
| Nucleotide-excision repair (NER) | Upregulated | Repairs UV photoproducts and bulky chemical adducts |
| Mismatch repair (MMR) | Upregulated | Corrects replication-introduced base mismatches |
| ATM/ATR kinase signalling | Upregulated | Coordinates DDR cascade and cell-cycle checkpoint response |
| TNF-alpha inflammatory cluster | Downregulated | Reduces pro-inflammatory milieu that suppresses DNA repair efficiency |
The methodological strength of the Campbell paper lies in the cMap approach: rather than testing GHK in a single cell line under artificial conditions, the transcriptomic signature was interrogated across multiple tissue contexts simultaneously, which makes the DNA-repair finding more generalisable than a single wet-lab experiment would allow.
Pickart & Margolina's 2018 review in Cosmetics is the most comprehensive synthesis of GHK-Cu research to date. Drawing on 45 years of accumulating data — including and building on the Campbell 2012 transcriptomic work — the authors mapped GHK's gene-modulation activity across six biological domains:
The 2018 review situated the DNA-repair finding within this multi-domain framework and argued that GHK's breadth of gene influence reflects its role as an endogenous biological messenger, not a pharmacological anomaly. The well-documented decline of plasma GHK with age becomes, in this framing, a loss of endogenous gene-repair signalling — a premise that underpins the strong interest among UAE research groups in GHK-Cu availability.
Before the transcriptomic era, GHK-Cu's research reputation was built on wound-healing models. Pickart's 2008 review in Advances in Wound Care synthesised several decades of in vitro and in vivo data, identifying mechanistically well-supported effects that later informed the gene-modulation hypotheses:
The 2008 wound-care review also documented GHK-Cu's role in accelerating wound contraction and re-epithelialisation in animal wound models. This mechanistic foundation made GHK-Cu a natural candidate for the later transcriptomic work — if the peptide could orchestrate such a coordinated repair response at the protein level, gene-level regulation was a logical upstream explanation.
For UAE investigators running multi-compound research protocols, GHK-Cu's profile is complementary rather than overlapping with the GH-axis and metabolic peptides also available from REVIVE LAB UAE:
| Peptide | Primary Research Domain | Mechanism Class |
|---|---|---|
| GHK-Cu | DNA repair gene modulation, tissue remodelling, antioxidant defence | Copper tripeptide / endogenous gene regulator |
| Tesamorelin | Visceral adipose reduction, GH axis modulation | GHRH analog (44-aa, trans-3-hexenoyl N-terminus) |
| Retatrutide | GLP-1/GIP/glucagon triple-agonism, metabolic research | GIP/GLP-1/glucagon triagonist |
GHK-Cu's gene-modulation breadth makes it a logical candidate for protocols where oxidative DNA damage, systemic inflammation, and connective tissue integrity are key variables. For UAE investigators wanting to buy GHK-Cu UAE, REVIVE LAB UAE is the only local supplier offering HPLC-verified material with same-day cold-chain dispatch.
REVIVE LAB UAE stocks GHK-Cu in two vial sizes optimised for research-scale work. These are the only two strengths available — no other concentrations are stocked:
| Vial Size | Form | Purity Standard | COA Available |
|---|---|---|---|
| GHK-Cu 50mg | Lyophilized powder | HPLC ≥98% | Yes — lot-specific |
| GHK-Cu 100mg | Lyophilized powder | HPLC ≥98% | Yes — lot-specific |
The 50mg vial suits short-duration mechanism studies with frequent lot verification. The 100mg vial reduces per-unit logistics overhead for longer investigational runs. Both formats ship with the same HPLC certification and cold-chain packaging standard.
Lyophilized GHK-Cu is considerably more stable than reconstituted solution. Key handling parameters for research-context storage:
REVIVE LAB UAE dispatches all GHK-Cu vials in validated cold-chain insulation with gel packs rated to hold 2-8°C through the longest UAE inter-emirate transit window — including summer deliveries to Fujairah and Al Ain.
REVIVE LAB UAE is the dedicated peptides UAE supplier for GHK-Cu — not a reseller, not an offshore freight forwarder. All vials are stocked in Dubai and dispatched same-day by refrigerated courier. Whether research is based in Dubai Marina, Business Bay, DIFC, JBR, JVC, Palm Jumeirah, Downtown, Jumeirah, Emirates Hills or Arabian Ranches — GHK-Cu same day Dubai is the standard, not an upgrade.
| Emirate / City | Delivery Window | Cash on Delivery | Discreet Packaging |
|---|---|---|---|
| Dubai (Marina, JBR, Business Bay, JVC, DIFC, Downtown, Palm, Jumeirah) | Same-day, 4–8 hours | Yes | Yes |
| Abu Dhabi (Corniche, Yas, Saadiyat, Reem) | Next-day, 18–24 hours | Yes | Yes |
| Sharjah | Same-day / next-day, 8–18 hours | Yes | Yes |
| Ajman | Next-day, 18–24 hours | Yes | Yes |
| Ras Al Khaimah (RAK) | Next-day, 18–24 hours | Yes | Yes |
| Fujairah | Next-day, 24 hours | Yes | Yes |
| Umm Al Quwain (UAQ) | Next-day, 18–24 hours | Yes | Yes |
| Al Ain | Next-day, 24 hours | Yes | Yes |
Payment options: cash on delivery Dubai and across all UAE emirates is the default — no upfront payment required. REVIVE LAB UAE also accepts USDT crypto pay Dubai via Binance Pay (TRC20 network) with a 5% pre-pay discount; confirm your TXID via WhatsApp after sending payment. Bank transfer is available on request.
REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched GHK-Cu across all 7 emirates. The verification standard matters: GHK-Cu is a small tripeptide that is straightforward to synthesise but easy to under-dose or contaminate at scale. Every REVIVE LAB UAE batch ships with a lot-specific HPLC certificate of analysis, not a generic spec sheet. Researchers can request COA via WhatsApp before ordering. GHK-Cu in stock UAE means stocked in Dubai right now — not en route from a warehouse overseas.
For the broader research stack — Retatrutide, Tesamorelin, GHK-Cu, BPC-157, TB-500, Semax, MOTS-c, NAD+ — REVIVE LAB UAE is the single-source peptides UAE catalogue built for research-context investigators. The operating model is built on one principle: HPLC-verified stock, cold-chain dispatch, same-day in Dubai, and GHK-Cu Dubai 24h delivery anywhere in the UAE.
REVIVE LAB UAE stocks GHK-Cu in 50mg and 100mg vials — both HPLC-verified to ≥98% purity with lot-specific COA available on request. These are the only two strengths stocked; no other concentrations are available. Orders are dispatched same-day in Dubai and within 24 hours to all other UAE emirates. Contact via WhatsApp to confirm current stock levels before placing an order.
Yes. GHK-Cu same day Dubai delivery is REVIVE LAB UAE's standard for orders placed before the daily dispatch cut-off. Cash on delivery Dubai is available by default — no upfront payment required unless you prefer the 5% USDT crypto pay discount. All shipments use plain, unbranded outer packaging. Same-day windows cover Dubai Marina, JBR, Business Bay, JVC, DIFC, Downtown, Palm Jumeirah, Jumeirah, Emirates Hills and Arabian Ranches.
REVIVE LAB UAE accepts cash on delivery across all seven UAE emirates, USDT TRC20 via Binance Pay with a 5% pre-pay discount (send TXID via WhatsApp to confirm), and bank transfer. There is no minimum order quantity for COD. Full payment and crypto wallet details are available on the GHK-Cu UAE product page.